Skip to main content
. 2020 Jun 30;11:1151. doi: 10.3389/fimmu.2020.01151

Figure 4.

Figure 4

Carbachol-induced [Ca2+] signal in the mAchR3 functional assay (A) and proliferation (B) of cholangiocytes (TFK-1 cells) constitutively expressing mAChR3 after incubation of immunoglobulins from PBC patients before therapy and in the follow-up (a) without any therapy, (b) during therapy with UDCA, (c) during therapy with immunosuppressive therapy. Data are given as percentage of RLUs (A) or counts per minute (cpm) (B) w/o incubation with immunoglobulins. –, median; gray, normal range; n.s., not significant.